MedaSystems
- 13/10/2023
- Seed
- Undisclosed Amount
MedaSystems provides Clinical Request Management software for biopharma companies.
MedaSystems’ software platform streamlines the handling of requests for experimental therapies from healthcare providers. Our secure, GxP compliant application provides support for Expanded Access, Post-Trial Access and Investigator-Initiated Studies.
- Industry Software Development
- Website https://medasystems.com/
- LinkedIn https://www.linkedin.com/company/medasystems/about/
Related People
Fiona SmytheFounder
I’m a health tech entrepreneur with a focus on patient-centric, enterprise products. At MedaSystems we're working to help patients, physicians and pharmaceutical manufacturers improve the process of applying for Expanded Access or Compassionate Use to experimental therapies. I helped launch mscripts, a digital medication communication platform used by pharmacies, health systems and life sciences companies to support patient adherence. The mscripts platform is used by millions of patients across the United States and changed the way people refill and manage medications. At mscripts, I led the product development, marketing, and customer success teams. Following the sale of mscripts to Cardinal Health, I worked with their innovation group, leading the development and rollout of software for scheduling COVID-19 immunizations and the brand strategy launch of OutcomesTM, a unified ecosystem for patient engagement, clinical intervention and pharmacy workflow solutions.